Obstetrics & Gynecology · Lebanon, NH
NPI
1396163465
Since 2014
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1 Medical Center Dr
Lebanon, NH, 03756
Phone (603) 650-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,845
88 services
Medicare patients, 2024
62
Average age 66
Drug cost, 2024
$14K
73 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Caroline B Stroup was code 99214 (office e&m - established), 18 times for 16 patients. In total Caroline B Stroup billed 88 services in 22 codes, and Medicare paid $5,845.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 18 | 16 | $66.77 | $1,202 |
| 99204 Office E&M - New | Facility | 15 | 15 | $89.40 | $1,341 |
By year: 2022 $8,083 for 72 services; 2023 $11K for 110 services; 2024 $5,845 for 88 services.
Medicare prescription drug claims, 2024
In 2024, the drug Caroline B Stroup prescribed most often to Medicare patients was Medroxyprogesterone Acetate, with 27 prescriptions and refills. In total Caroline B Stroup wrote 73 Medicare prescriptions that cost $14K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Medroxyprogesterone Acetate Generic | 27 | 33 | Under 11 | $223 |
| Norethindrone Acetate Generic | 13 | 21 | Under 11 | $2,035 |
| Estradiol Generic | 11 | 32 | Under 11 | $1,121 |
Brand drugs: - claims; generic drugs: 63 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Caroline B Stroup were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.